Flagship Pioneering’s Valo Health and Khosla Ventures Acquisition Co. abandoned their SPAC merger on the eve of a scheduled shareholder vote on whether to approve the deal. The parties described the decision as mutual, and they cited “market conditions.”
A round-up of funding announcements this week. Other companies that have raised new venture capital funding rounds this week include Genespire, HeartVista and Particle Health and Vida.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The SoftBank Vision Fund led the round, which the company said would be used t expand its reach and support future clinical studies.
The company's platform consists of a digital assessment to measure memory health and an associated program meant to drive better healthy behaviors and training exercises as a way to improve cognitive health.
The San Francisco-based startup's platform aids care coordinators to assess and identify both clinical and sociodemographic risk factors for chronic illnesses like diabetes, COPD, chronic kidney disease, depression and congestive heart failure.
The company plans to use blockchain and other technologies to develop the genomic data marketplace, under a partnership with Veritas Genetics.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The funding comes as competition for the Medicare population by startup and growth-stage companies intensifies, not only from other technology-led healthcare organizations like Iora but also from the likes of CVS Health and more established companies like CareMore.
The company has enrolled nearly 250,000 members across six states so far in 2018. Oscar has also projected sales of more than $1 billion in gross premium revenue.
Healthcare investments hit $3.8 billion in the second quarter of 2017, marking a spike in these deals and a milestone for the healthcare industry in general, according to StartUp Health's half year report.
Neurotrack has announced the availabilty of its webcam-based test that is aimed to help those with diseases like Alzheimer's track recognition memory and cognitive function in order to detect risks before behavioral symptoms show up - and it only takes five minutes.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
HealthTap has raised $24 million in Series B financing, with Khosla Ventures leading the round. Previous investors Mayfield Fund and Mohr Davidow Ventures also participated. Keith Rabois will join HealthTap’s board of directors, and Vinod Khosla is now an advisor. On HealthTap’s site and mobile app, patients ask questions of doctors who answer at no […]